|
nyse:a
|
1526
|
Apr 21st, 2024 12:00AM
|
Agilent Technologies
|
584K
|
17326
|
Open
|
|
Apr 21st, 2024 03:31AM
|
Apr 21st, 2024 03:31AM
|
Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio.
Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories.
Additionally, the unique expertise of Agilent’s CrossLab and technical teams provides valuable insight and support to our customers, helping them fully optimize their laboratories and resources to better focus on what's important: bringing great science to life.
In fiscal 2022, Agilent Technologies generated revenue of (US) $6.85 billion.
|
Open
|
Diagnostics & Genomics, Chemical Analysis, Life Sciences, Environmental & Forensics, Food Safety, Pharmaceutical, Cancer Research, Pathology, Agriculture, Clinical Diagnostics, and Biopharma
|
Open
|
5301 Stevens Creek Boulevard
|
Santa Clara
|
CA
|
US
|
95051
|
|
Agilent Technologies
|
Industrials
|
Electronic & Electrical Equipment
|
|
nyse:a
|
1526
|
Apr 20th, 2024 12:00AM
|
Agilent Technologies
|
584K
|
17326
|
Open
|
|
Apr 20th, 2024 12:39AM
|
Apr 20th, 2024 05:53PM
|
Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio.
Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories.
Additionally, the unique expertise of Agilent’s CrossLab and technical teams provides valuable insight and support to our customers, helping them fully optimize their laboratories and resources to better focus on what's important: bringing great science to life.
In fiscal 2022, Agilent Technologies generated revenue of (US) $6.85 billion.
|
Open
|
Diagnostics & Genomics, Chemical Analysis, Life Sciences, Environmental & Forensics, Food Safety, Pharmaceutical, Cancer Research, Pathology, Agriculture, Clinical Diagnostics, and Biopharma
|
Open
|
5301 Stevens Creek Boulevard
|
Santa Clara
|
CA
|
US
|
95051
|
|
Agilent Technologies
|
Industrials
|
Electronic & Electrical Equipment
|
|
nyse:a
|
1526
|
Apr 19th, 2024 12:00AM
|
Agilent Technologies
|
584K
|
17321
|
Open
|
|
Apr 19th, 2024 04:53AM
|
Apr 19th, 2024 04:53AM
|
Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio.
Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories.
Additionally, the unique expertise of Agilent’s CrossLab and technical teams provides valuable insight and support to our customers, helping them fully optimize their laboratories and resources to better focus on what's important: bringing great science to life.
In fiscal 2022, Agilent Technologies generated revenue of (US) $6.85 billion.
|
Open
|
Diagnostics & Genomics, Chemical Analysis, Life Sciences, Environmental & Forensics, Food Safety, Pharmaceutical, Cancer Research, Pathology, Agriculture, Clinical Diagnostics, and Biopharma
|
Open
|
5301 Stevens Creek Boulevard
|
Santa Clara
|
CA
|
US
|
95051
|
|
Agilent Technologies
|
Industrials
|
Electronic & Electrical Equipment
|
|
nyse:a
|
1526
|
Apr 18th, 2024 12:00AM
|
Agilent Technologies
|
584K
|
17321
|
Open
|
|
Apr 18th, 2024 01:33AM
|
Apr 18th, 2024 07:13PM
|
Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio.
Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories.
Additionally, the unique expertise of Agilent’s CrossLab and technical teams provides valuable insight and support to our customers, helping them fully optimize their laboratories and resources to better focus on what's important: bringing great science to life.
In fiscal 2022, Agilent Technologies generated revenue of (US) $6.85 billion.
|
Open
|
Diagnostics & Genomics, Chemical Analysis, Life Sciences, Environmental & Forensics, Food Safety, Pharmaceutical, Cancer Research, Pathology, Agriculture, Clinical Diagnostics, and Biopharma
|
Open
|
5301 Stevens Creek Boulevard
|
Santa Clara
|
CA
|
US
|
95051
|
|
Agilent Technologies
|
Industrials
|
Electronic & Electrical Equipment
|
|
nyse:a
|
1526
|
Apr 17th, 2024 12:00AM
|
Agilent Technologies
|
584K
|
17324
|
Open
|
|
Apr 17th, 2024 04:34AM
|
Apr 17th, 2024 03:39PM
|
Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio.
Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories.
Additionally, the unique expertise of Agilent’s CrossLab and technical teams provides valuable insight and support to our customers, helping them fully optimize their laboratories and resources to better focus on what's important: bringing great science to life.
In fiscal 2022, Agilent Technologies generated revenue of (US) $6.85 billion.
|
Open
|
Diagnostics & Genomics, Chemical Analysis, Life Sciences, Environmental & Forensics, Food Safety, Pharmaceutical, Cancer Research, Pathology, Agriculture, Clinical Diagnostics, and Biopharma
|
Open
|
5301 Stevens Creek Boulevard
|
Santa Clara
|
CA
|
US
|
95051
|
|
Agilent Technologies
|
Industrials
|
Electronic & Electrical Equipment
|
|
nyse:a
|
1526
|
Apr 16th, 2024 12:00AM
|
Agilent Technologies
|
583K
|
17327
|
Open
|
|
Apr 16th, 2024 12:25AM
|
Apr 16th, 2024 11:56AM
|
Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio.
Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories.
Additionally, the unique expertise of Agilent’s CrossLab and technical teams provides valuable insight and support to our customers, helping them fully optimize their laboratories and resources to better focus on what's important: bringing great science to life.
In fiscal 2022, Agilent Technologies generated revenue of (US) $6.85 billion.
|
Open
|
Diagnostics & Genomics, Chemical Analysis, Life Sciences, Environmental & Forensics, Food Safety, Pharmaceutical, Cancer Research, Pathology, Agriculture, Clinical Diagnostics, and Biopharma
|
Open
|
5301 Stevens Creek Boulevard
|
Santa Clara
|
CA
|
US
|
95051
|
|
Agilent Technologies
|
Industrials
|
Electronic & Electrical Equipment
|
|
nyse:a
|
1526
|
Apr 15th, 2024 12:00AM
|
Agilent Technologies
|
583K
|
17319
|
Open
|
|
Apr 15th, 2024 05:09AM
|
Apr 15th, 2024 05:37PM
|
Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio.
Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories.
Additionally, the unique expertise of Agilent’s CrossLab and technical teams provides valuable insight and support to our customers, helping them fully optimize their laboratories and resources to better focus on what's important: bringing great science to life.
In fiscal 2022, Agilent Technologies generated revenue of (US) $6.85 billion.
|
Open
|
Diagnostics & Genomics, Chemical Analysis, Life Sciences, Environmental & Forensics, Food Safety, Pharmaceutical, Cancer Research, Pathology, Agriculture, Clinical Diagnostics, and Biopharma
|
Open
|
5301 Stevens Creek Boulevard
|
Santa Clara
|
CA
|
US
|
95051
|
|
Agilent Technologies
|
Industrials
|
Electronic & Electrical Equipment
|
|
nyse:a
|
1526
|
Apr 14th, 2024 12:00AM
|
Agilent Technologies
|
583K
|
17310
|
Open
|
|
Apr 13th, 2024 11:57PM
|
Apr 13th, 2024 11:57PM
|
Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio.
Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories.
Additionally, the unique expertise of Agilent’s CrossLab and technical teams provides valuable insight and support to our customers, helping them fully optimize their laboratories and resources to better focus on what's important: bringing great science to life.
In fiscal 2022, Agilent Technologies generated revenue of (US) $6.85 billion.
|
Open
|
Diagnostics & Genomics, Chemical Analysis, Life Sciences, Environmental & Forensics, Food Safety, Pharmaceutical, Cancer Research, Pathology, Agriculture, Clinical Diagnostics, and Biopharma
|
Open
|
5301 Stevens Creek Boulevard
|
Santa Clara
|
CA
|
US
|
95051
|
|
Agilent Technologies
|
Industrials
|
Electronic & Electrical Equipment
|
|
nyse:a
|
1526
|
Apr 13th, 2024 12:00AM
|
Agilent Technologies
|
583K
|
17311
|
Open
|
|
Apr 12th, 2024 11:48PM
|
Apr 13th, 2024 12:22PM
|
Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio.
Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories.
Additionally, the unique expertise of Agilent’s CrossLab and technical teams provides valuable insight and support to our customers, helping them fully optimize their laboratories and resources to better focus on what's important: bringing great science to life.
In fiscal 2022, Agilent Technologies generated revenue of (US) $6.85 billion.
|
Open
|
Diagnostics & Genomics, Chemical Analysis, Life Sciences, Environmental & Forensics, Food Safety, Pharmaceutical, Cancer Research, Pathology, Agriculture, Clinical Diagnostics, and Biopharma
|
Open
|
5301 Stevens Creek Boulevard
|
Santa Clara
|
CA
|
US
|
95051
|
|
Agilent Technologies
|
Industrials
|
Electronic & Electrical Equipment
|
|
nyse:a
|
1526
|
Apr 12th, 2024 12:00AM
|
Agilent Technologies
|
583K
|
17315
|
Open
|
|
Apr 11th, 2024 11:55PM
|
Apr 12th, 2024 09:18AM
|
Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio.
Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories.
Additionally, the unique expertise of Agilent’s CrossLab and technical teams provides valuable insight and support to our customers, helping them fully optimize their laboratories and resources to better focus on what's important: bringing great science to life.
In fiscal 2022, Agilent Technologies generated revenue of (US) $6.85 billion.
|
Open
|
Diagnostics & Genomics, Chemical Analysis, Life Sciences, Environmental & Forensics, Food Safety, Pharmaceutical, Cancer Research, Pathology, Agriculture, Clinical Diagnostics, and Biopharma
|
Open
|
5301 Stevens Creek Boulevard
|
Santa Clara
|
CA
|
US
|
95051
|
|
Agilent Technologies
|
Industrials
|
Electronic & Electrical Equipment
|